APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Selected research

Market Structure

Global Codeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchCodeine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Codeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

This report provides an overview of the global Codeine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Codeine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Codeine market size, projected growth trends, production technologies, key applications, and end-use industries.

Codeine Segment by Company

Taiji

Mallinckrodt

TEVA

Johnson & Johnson

Medreich

Sanofi Aventis

Cipla

Hikma

Pharmaceutical Associates

Novartis

Apotex

Mylan

Aristo Pharma GmbH

Lannett Company

Laboratoire Riva

Codeine Segment by Ingredient

Single-ingredient Codeine

Multi-ingredient Medications

Codeine Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Codeine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Codeine Industry Trends Table 2. Codeine Industry Drivers Table 3. Codeine Industry Opportunities and Challenges Table 4. Codeine Industry Restraints Table 5. Global Codeine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Codeine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Codeine Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Codeine Sales Market Share by Manufacturers Table 9. Global Codeine Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Codeine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Codeine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Codeine Manufacturers, Product Type & Application Table 13. Global Codeine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Codeine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single-ingredient Codeine Table 17. Major Manufacturers of Multi-ingredient Medications Table 18. Global Codeine Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Codeine Sales by Type (2021-2026) & (M Units) Table 20. Global Codeine Sales by Type (2027-2032) & (M Units) Table 21. Global Codeine Sales Market Share by Type (2021-2026) Table 22. Global Codeine Sales Market Share by Type (2027-2032) Table 23. Global Codeine Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Codeine Revenue by Type (2021-2026) & (M Units) Table 25. Global Codeine Revenue by Type (2027-2032) & (M Units) Table 26. Global Codeine Revenue Market Share by Type (2021-2026) Table 27. Global Codeine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Narcotic Analgesic Table 29. Major Manufacturers of Antitussive Table 30. Major Manufacturers of Others Table 31. Global Codeine Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Codeine Sales by Application (2021-2026) & (M Units) Table 33. Global Codeine Sales by Application (2027-2032) & (M Units) Table 34. Global Codeine Sales Market Share by Application (2021-2026) Table 35. Global Codeine Sales Market Share by Application (2027-2032) Table 36. Global Codeine Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Codeine Revenue by Application (2021-2026) & (M Units) Table 38. Global Codeine Revenue by Application (2027-2032) & (M Units) Table 39. Global Codeine Revenue Market Share by Application (2021-2026) Table 40. Global Codeine Revenue Market Share by Application (2027-2032) Table 41. Global Codeine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Codeine Sales by Region (2021-2026) & (M Units) Table 43. Global Codeine Sales Market Share by Region (2021-2026) Table 44. Global Codeine Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Codeine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Codeine Sales by Country (2021-2026) & (M Units) Table 48. North America Codeine Sales by Country (2027-2032) & (M Units) Table 49. Europe Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Codeine Sales by Country (2021-2026) & (M Units) Table 51. Europe Codeine Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Codeine Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Codeine Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Codeine Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Codeine Sales by Country (2027-2032) & (M Units) Table 58. Global Codeine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Codeine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Codeine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Codeine Revenue Market Share by Region (2021-2026) Table 62. Global Codeine Revenue Market Share by Region (2027-2032) Table 63. Taiji Company Information Table 64. Taiji Business Overview Table 65. Taiji Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Taiji Codeine Product Portfolio Table 67. Taiji Recent Development Table 68. Mallinckrodt Company Information Table 69. Mallinckrodt Business Overview Table 70. Mallinckrodt Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mallinckrodt Codeine Product Portfolio Table 72. Mallinckrodt Recent Development Table 73. TEVA Company Information Table 74. TEVA Business Overview Table 75. TEVA Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. TEVA Codeine Product Portfolio Table 77. TEVA Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Codeine Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Medreich Company Information Table 84. Medreich Business Overview Table 85. Medreich Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Medreich Codeine Product Portfolio Table 87. Medreich Recent Development Table 88. Sanofi Aventis Company Information Table 89. Sanofi Aventis Business Overview Table 90. Sanofi Aventis Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sanofi Aventis Codeine Product Portfolio Table 92. Sanofi Aventis Recent Development Table 93. Cipla Company Information Table 94. Cipla Business Overview Table 95. Cipla Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Cipla Codeine Product Portfolio Table 97. Cipla Recent Development Table 98. Hikma Company Information Table 99. Hikma Business Overview Table 100. Hikma Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hikma Codeine Product Portfolio Table 102. Hikma Recent Development Table 103. Pharmaceutical Associates Company Information Table 104. Pharmaceutical Associates Business Overview Table 105. Pharmaceutical Associates Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pharmaceutical Associates Codeine Product Portfolio Table 107. Pharmaceutical Associates Recent Development Table 108. Novartis Company Information Table 109. Novartis Business Overview Table 110. Novartis Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Novartis Codeine Product Portfolio Table 112. Novartis Recent Development Table 113. Apotex Company Information Table 114. Apotex Business Overview Table 115. Apotex Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Apotex Codeine Product Portfolio Table 117. Apotex Recent Development Table 118. Mylan Company Information Table 119. Mylan Business Overview Table 120. Mylan Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Mylan Codeine Product Portfolio Table 122. Mylan Recent Development Table 123. Aristo Pharma GmbH Company Information Table 124. Aristo Pharma GmbH Business Overview Table 125. Aristo Pharma GmbH Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Aristo Pharma GmbH Codeine Product Portfolio Table 127. Aristo Pharma GmbH Recent Development Table 128. Lannett Company Company Information Table 129. Lannett Company Business Overview Table 130. Lannett Company Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Lannett Company Codeine Product Portfolio Table 132. Lannett Company Recent Development Table 133. Laboratoire Riva Company Information Table 134. Laboratoire Riva Business Overview Table 135. Laboratoire Riva Codeine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Laboratoire Riva Codeine Product Portfolio Table 137. Laboratoire Riva Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Codeine Distributors List Table 141. Codeine Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Codeine Product Image Figure 2. Global Codeine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Market Size (2021-2032) & (US$ Million) Figure 4. Global Codeine Sales (2021-2032) & (M Units) Figure 5. Global Codeine Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Codeine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single-ingredient Codeine Image Figure 9. Multi-ingredient Medications Image Figure 10. Global Codeine Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Codeine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Codeine Sales Market Share by Type (2021-2032) Figure 13. Global Codeine Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Codeine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Codeine Revenue Market Share by Type (2021-2032) Figure 16. Narcotic Analgesic Image Figure 17. Antitussive Image Figure 18. Others Image Figure 19. Global Codeine Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Codeine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Codeine Sales Market Share by Application (2021-2032) Figure 22. Global Codeine Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Codeine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Codeine Revenue Market Share by Application (2021-2032) Figure 25. North America Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Codeine Sales Market Share by Country (2021-2032) Figure 27. U.S. Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Codeine Sales Market Share by Country (2021-2032) Figure 32. Germany Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Codeine Sales Market Share by Country (2021-2032) Figure 39. China Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Codeine Sales Market Share by Country (2021-2032) Figure 47. Brazil Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Codeine Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Codeine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Codeine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Codeine Revenue (2021-2032) & (US$ Million) Figure 58. North America Codeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Codeine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Codeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Codeine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Codeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Codeine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Codeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Codeine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Codeine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • Taiji
  • Mallinckrodt
  • TEVA
  • Johnson & Johnson
  • Medreich
  • Sanofi Aventis
  • Cipla
  • Hikma
  • Pharmaceutical Associates
  • Novartis
  • Apotex
  • Mylan
  • Aristo Pharma GmbH
  • Lannett Company
  • Laboratoire Riva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Codeine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Codeine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Codeine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Codeine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Codeine Market Dynamics
  1. 2.1 Codeine Industry Trends
  2. 2.2 Codeine Industry Drivers
  3. 2.3 Codeine Industry Opportunities and Challenges
  4. 2.4 Codeine Industry Restraints
3 Codeine Market by Manufacturers
  1. 3.1 Global Codeine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Codeine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Codeine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Codeine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Codeine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Codeine Manufacturers, Product Type & Application
  7. 3.7 Global Codeine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Codeine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Codeine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Codeine Tier 1, Tier 2, and Tier 3
4 Codeine Market by Type
  1. 4.1 Codeine Type Introduction
  2. 4.1.1 Single-ingredient Codeine
  3. 4.1.2 Multi-ingredient Medications
  4. 4.2 Global Codeine Sales by Type
  5. 4.2.1 Global Codeine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Sales by Type (2021-2032)
  7. 4.2.3 Global Codeine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Codeine Revenue by Type
  9. 4.3.1 Global Codeine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Codeine Revenue by Type (2021-2032)
  11. 4.3.3 Global Codeine Revenue Market Share by Type (2021-2032)
5 Codeine Market by Application
  1. 5.1 Codeine Application Introduction
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Sales by Application
  6. 5.2.1 Global Codeine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Sales by Application (2021-2032)
  8. 5.2.3 Global Codeine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Codeine Revenue by Application
  10. 5.3.1 Global Codeine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Codeine Revenue by Application (2021-2032)
  12. 5.3.3 Global Codeine Revenue Market Share by Application (2021-2032)
6 Global Codeine Sales by Region
  1. 6.1 Global Codeine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Sales by Region (2021-2032)
  3. 6.2.1 Global Codeine Sales by Region (2021-2026)
  4. 6.2.2 Global Codeine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Codeine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Codeine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Codeine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Codeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Codeine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Codeine Revenue by Region
  1. 7.1 Global Codeine Revenue by Region
  2. 7.1.1 Global Codeine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Codeine Revenue by Region (2021-2026)
  4. 7.1.3 Global Codeine Revenue by Region (2027-2032)
  5. 7.1.4 Global Codeine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Codeine Revenue (2021-2032)
  8. 7.2.2 North America Codeine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Codeine Revenue (2021-2032)
  11. 7.3.2 Europe Codeine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Codeine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Codeine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Codeine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Codeine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Taiji
  2. 8.1.1 Taiji Company Information
  3. 8.1.2 Taiji Business Overview
  4. 8.1.3 Taiji Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Taiji Codeine Product Portfolio
  6. 8.1.5 Taiji Recent Developments
  7. 8.2 Mallinckrodt
  8. 8.2.1 Mallinckrodt Company Information
  9. 8.2.2 Mallinckrodt Business Overview
  10. 8.2.3 Mallinckrodt Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mallinckrodt Codeine Product Portfolio
  12. 8.2.5 Mallinckrodt Recent Developments
  13. 8.3 TEVA
  14. 8.3.1 TEVA Company Information
  15. 8.3.2 TEVA Business Overview
  16. 8.3.3 TEVA Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TEVA Codeine Product Portfolio
  18. 8.3.5 TEVA Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Codeine Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Medreich
  26. 8.5.1 Medreich Company Information
  27. 8.5.2 Medreich Business Overview
  28. 8.5.3 Medreich Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medreich Codeine Product Portfolio
  30. 8.5.5 Medreich Recent Developments
  31. 8.6 Sanofi Aventis
  32. 8.6.1 Sanofi Aventis Company Information
  33. 8.6.2 Sanofi Aventis Business Overview
  34. 8.6.3 Sanofi Aventis Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Aventis Codeine Product Portfolio
  36. 8.6.5 Sanofi Aventis Recent Developments
  37. 8.7 Cipla
  38. 8.7.1 Cipla Company Information
  39. 8.7.2 Cipla Business Overview
  40. 8.7.3 Cipla Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cipla Codeine Product Portfolio
  42. 8.7.5 Cipla Recent Developments
  43. 8.8 Hikma
  44. 8.8.1 Hikma Company Information
  45. 8.8.2 Hikma Business Overview
  46. 8.8.3 Hikma Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Codeine Product Portfolio
  48. 8.8.5 Hikma Recent Developments
  49. 8.9 Pharmaceutical Associates
  50. 8.9.1 Pharmaceutical Associates Company Information
  51. 8.9.2 Pharmaceutical Associates Business Overview
  52. 8.9.3 Pharmaceutical Associates Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmaceutical Associates Codeine Product Portfolio
  54. 8.9.5 Pharmaceutical Associates Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Codeine Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Codeine Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Mylan
  68. 8.12.1 Mylan Company Information
  69. 8.12.2 Mylan Business Overview
  70. 8.12.3 Mylan Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mylan Codeine Product Portfolio
  72. 8.12.5 Mylan Recent Developments
  73. 8.13 Aristo Pharma GmbH
  74. 8.13.1 Aristo Pharma GmbH Company Information
  75. 8.13.2 Aristo Pharma GmbH Business Overview
  76. 8.13.3 Aristo Pharma GmbH Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aristo Pharma GmbH Codeine Product Portfolio
  78. 8.13.5 Aristo Pharma GmbH Recent Developments
  79. 8.14 Lannett Company
  80. 8.14.1 Lannett Company Company Information
  81. 8.14.2 Lannett Company Business Overview
  82. 8.14.3 Lannett Company Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lannett Company Codeine Product Portfolio
  84. 8.14.5 Lannett Company Recent Developments
  85. 8.15 Laboratoire Riva
  86. 8.15.1 Laboratoire Riva Company Information
  87. 8.15.2 Laboratoire Riva Business Overview
  88. 8.15.3 Laboratoire Riva Codeine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Laboratoire Riva Codeine Product Portfolio
  90. 8.15.5 Laboratoire Riva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Codeine Value Chain Analysis
  2. 9.1.1 Codeine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Codeine Production Mode & Process
  6. 9.2 Codeine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Codeine Distributors
  9. 9.2.3 Codeine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst